Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure.
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure. — المؤلف: Carraway, Hetty E — Hematology. American Society of Hematology. Education Program 20170515
- المؤلف
- Carraway, Hetty E
- النشر
- Hematology. American Society of Hematology. Education Program 20170515
- الوصف
- 470-477 p.
- الموضوعات
- Azacitidine؛ Drug Resistance؛ Humans؛ Lenalidomide؛ Myelodysplastic Syndromes؛ Thalidomide